Point72 Asset Management, L.P. 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Point72 Asset Management, L.P. | 228,922 0.300% | -4,915,715 (-95.55%) | Filing |
| 2021-09-07 4:35 pm Purchase | 2021-08-25 | 13G | Theravance Biopharma, Inc. TBPH | Point72 Asset Management, L.P. | 5,144,637 7.000% | 5,144,637 (New Position) | Filing |